Stay updated on MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:40:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial for the MRTX0902 drug and the addition of new identifiers and revision information.
    Difference
    23%
    Check dated 2025-04-16T13:24:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The study has increased its number of locations from 21 to 24, with updates to specific locations in Minneapolis, Austin, and Tyler, Texas. Additionally, the revision version has been updated from v2.14.3 to v2.14.4.
    Difference
    3%
    Check dated 2025-04-09T06:51:58.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:58:36.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page has updated the number of study locations from 19 to 21 and added specific details for new locations in Colorado and Delaware.
    Difference
    2%
    Check dated 2025-03-18T08:43:56.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page now indicates that a study has expanded to 19 locations and is actively recruiting participants, with specific details about a new site in Baltimore, Maryland, and a contact person at Texas Oncology-Fort Worth Cancer Center.
    Difference
    2%
    Check dated 2025-03-03T23:53:57.000Z thumbnail image

Stay in the know with updates to MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.